Introduction
Pseudomonas aeruginosa, a Gram-negative opportunistic bacterium, plays an important role in human infections, causing severe complications in burns, major surgery or organ transplant patients [1] . In patients with cystic fibrosis, P aeruginosa is recognized as the principal cause of morbidity and mortality [2] . Immunoprophylaxis and/or immunotherapy may be an effective method for controlling P. aeruginosa infections, and for this reason the development of a vaccine has become a priority. Essential to this end is the identification of protective antigens suitable as vaccine candidates. There have been several reviews recently which examine the range of vaccine approaches that are currently been pursued [3] [4] [5] .
Previous investigations in our laboratory have demonstrated the potential of mucosal immunization with cytosol derived proteins to protect against P. aeruginosa infection in a rat model of acute respiratory infection [6, 7] .
The use of non-integral outer membrane proteins as vaccine candidates have had precedence in
Helicobacter pylori studies, where it has been suggested that these may ultimately be secreted or externalised through lysis of the bacteria [8] [9] [10] [11] [12] [13] . In addition, externalisation of cytosolic or periplasmic proteins in Gram negative bacteria may occur through specific transporter mechanisms or through the formation of micro-vesicles [14] [15] [16] [17] [18] [19] .
In this paper we build on our previous research into non-integral proteins as protective antigens against P aeruginosa in a rodent model of acute lung infection. We have also investigated the contribution of innate and acquired immune responses to the enhanced bacterial clearance that were observed following lung challenge with live organisms.
Methods

Bacteria
The mucoid P. aeruginosa isolate used for this study, strain 385 (Serotype 2; phagetype 21/44/109/110X/1214) (Pa385), has been studied previously and was originally isolated from a chronically infected cystic fibrosis patient [7, 20] .
Protein Purification
Seven proteins were purified from Pa385 as previously described [6, 7] . The proteins were identified as azurin, acyl carrier protein (ACP), amidase, amidopeptidase, catalase E (KatE) and catalase A (KatA). One protein with a molecular weight of 13 kDa was considered a novel protein and assigned an identification as Pa13. Possible LPS contamination in protein preparations was assessed by the E-toxate Limulus lysate test (Sigma, St. Louis, MO, USA) (detection limit 0.015 endotoxin untis/ml). No detectable levels of endotoxin were measured in any of the protein preparations.
Immunization and Bacterial Challenge
All animal experiments were conducted with the approval of the institutional animal care and ethics committee. Specific Pathogen Free (SPF) Dark agouti (DA) male rats aged between 8 and 10 weeks were maintained and prepared for immunization as previously described [7] . Animals were immunized sub-serosally under anaesthesia into Peyer's patch (IPP) on day 0. This was followed by an intratracheal boost on day 14 and live challenge on day 21, as previously described [7] . Immunization dosages are detailed in Table 1 . Doses varied due to the availability of purified native protein. Animals were sacrificed 4 hours post challenge and bronchoalveolar lavage (BAL) and lung tissue and blood were collected. BAL and lung tissue were prepared for bacterial culture as previously described [6] . Serum was prepared from blood.
Preparation of BAL for cell counts
Cytospin slides were prepared to determine percentages of polymorphonuclear leukocytes (PMNs), macrophages and other cells present in the BAL fluid. A 100ul aliquot of BAL fluid was spun for 10 min. at 4.5 x g onto a microscopic slide using a cytospin apparatus (Shandon Inc.
Pittsburgh, Pa, USA). The slides were fixed and stained in Diff Quick (Veterinary Medical Surgical Supply Pty Ltd, Maryville, NSW, Australia), and percentages were determined from three differential cell counts on each slide. Mean percentages ± the standard error, were calculated from the collected group data.
Antigen-specific lymphocyte proliferation assay for ACP and KatA
Antigen-specific lymphocyte proliferation proliferation for ACP and KatA were conducted on lymhocytes obtained from the mesenteric lymph nodes (MLN) and cultured as previously described [7] . Lymphocyte proliferation was estimated by determining 
Flow Cytometry
Pa385 was grown to mid logarithmic phase in nutrient broth [7] , and incubated in either nonimmune serum or Pa13, azurine, ACP, amidase, aminopeptidase, KatA or KatE immunized serum at a 1:50 dilution followed by incubation in fluorescein conjugated anti-rat IgG. A total of 20,000 cells were counted and data acquired in the instrument status of logarithmic mode for forward scatter, side scatter and fluorescence.
Antigen-specific ELISA for IgA and IgG antibodies against ACP and Catalase A
Polysorb microtitre wells (Nunc, Roskilde, Denmark) were coated with 1µg of purified ACP or KatA in 1ml of coating buffer. The methodology and mean ELISA titres were calculated as previously described [7] .
Statistical analysis
Data were expressed as the mean and standard error of the mean. Statistical significance between groups was evaluated using one way analysis of variance or independent t tests. All analyses were carried out using WINKS 4.5 statistics program by Texasoft.
Results
Effects of immunization on pulmonary clearance from the BAL and lung tissue
The bacterial recovery from the BAL and lung are presented in 
Recruitment of phagocytic cells
The total cell count and differential cell proportions are presented in Table 2 . The total number of cells present in the BAL four hours post-challenge was significantly higher than the corresponding controls for Pa13 (p<0.05), KatE (p<0.05) and KatA (p<0.01). Overall, lung challenge of immunized animals with live bacteria tended to increase the proportion of PMNs in the cell count with the exception of azurin where no increase was observed. This increase was significant for Pa13 (p<0.01) KatE (p<0.01) and KatA (p<0.05)
Antigen-specific cell surface reactivity
The presence of antigens on the bacterial surface was assessed using flow cytometry and is shown in Fig. 2 . Azurin, ACP, amidase, amidopetidase, KatE and KatA were all detected on surface of
Pa385 as demonstrated by a shift of the curve to the right when the bacteria where incubated with immune serum. In contrast to ACP, amidase, amidopeptidase, KatE and KatA, the relative curve shift for azurin suggested that it was the least abundant of these proteins on the bacterial cell surface. No appreciable surface reactivity could be demonstrated for Pa13.
Antibody responses to ACP and KatA following immunization
Antibody levels detected in the BAL and serum against ACP and KatA are presented in Fig.3 .
Significant levels of ACP-specific IgG were detected in both BAL (p<0.05) and sera (p<0.01), as well as significant levels of anti-ACP IgA (p<0.05) in both BAL and sera.
KatA immunization resulted in significant levels of anti-KatA IgG (p<0.05) in both BAL and sera, however, significant levels of KatA-specific IgA were only observed in the BAL (p<0.05).
ACP and KatA specific lymphocyte proliferation following immunization
The lymphocyte stimulation indexes for ACP and KatA are shown in Fig.4 . Lymphocytes from rats immunized with ACP showed a significant proliferative response compared with the nonimmune control group (p<0.01) Similarly the KatA immunized animals also showed a significant proliferative response when compared against their respective control group (p<0.001). A direct comparison of the degree of stimulation for these antigens showed an approximate five-fold greater response for KatA compared with ACP.
Discussion
The mucosal immunization regimen of intestinal priming followed by a pulmonary boost has been found to very useful in identifying potential vaccine antigens against a number of respiratory pathogens [6, 7, [21] [22] [23] . Our studies on P. aeruginosa have demonstrated that immunization with any one of 5 non-integral OMPs induces enhanced clearance of P. aeruginosa from the lungs following challenge with live bacteria. These proteins have been identified as amidase, amidopeptidase, KatE, KatA and Pa13 (a novel 13 kDa protein).
Studies of mucosal immunization with killed whole cell preparations of P. aeruginosa have been
shown to induce protective immunity and the immune mechanisms described have predominantly been cell-mediated [24] [25] [26] . These protective responses are induced by CD4-T cells through T-cell derived cytokines, activation of macrophages, and subsequent recruitment and activation of PMNs.
Macrophages play an important role in regulating PMN recruitment through the release of pro-and anti-inflammatory cytokines [27] [28] [29] [30] . Saba [31] found that epithelial cells responding to pathogens, also produced cytokines and chemokines involved in recruiting PMNs. This response was found to be excessive in patients with cystic fibrosis and could contribute, in part, to the excessive tissue damage that occurs these patients during an infection episode. In the present study, the 5 antigens (amidase, amidopeptidase, KatE, KatA and Pa13) which induced significant clearance of live bacteria from the lungs of acutely infected animals showed an overall trend to have a greater number of total white cells as well as a greater proportion of PMNs in their BAL.
Both the proportion of PMNs and the total cell counts were significantly greater than that observed in the unimmunized controls for 3 of the 5 proteins (KatE, KatA and Pa13). Hence, the early recruitment of PMNs to the lungs at the onset of infection with P.aeruginosa was clearly an important mechanism induced through immunization for protection against the initial infection and potentially eventual colonization. The proportion of macrophages recruited to the lungs following live bacterial challenge did not seem to be greatly affected by immunization, although, the relative proportion of macrophages in animals that were immunized with KatA was smaller because the number of PMNs was significantly higher than in other groups . Studies by Buret and coworkers [32] using P. aeruginosa whole killed cell immunization, found significantly increased macrophage numbers and activation in protected animals at four hours post challenge. A study of the nontypable Haemophilus influenzae OMP antigen P6, in the same experimental model found no differences in the proportion of PMNs or macrophages between immune and non-immune animals but did demonstrate increased total numbers of white cells in the BAL of animals that received an IT booster immunization [33] . From these studies and our previous work it is clear that different antigens when administered mucosally are capable of enhancing bacterial clearance from the lungs by a number of mechanisms and the effector immune mechanisms may differ between antigens and microbes.
Enhanced pulmonary clearance of P. aeruginosa has been reported following adoptive transfer of CD4+ T cells from immunized to naive rats. This protection was antigen specific and occurred in the absence of antibody in either serum or BAL [24, 34] . In this study in vitro lymphocyte proliferation of KatA and ACP was examined. Immunization with KatA induced significant clearance of bacteria from the lung compared to control animals whilst ACP did not. Whilst a significant proliferation response was observed for both proteins the degree of stimulation for
KatA was approximately five-fold greater compared with ACP. Further studies are required to determine if there is a threshold proliferative response needed before T cells are able to drive cellular responses in the lung over and above that required for memory.
Antibody responses are and important component of the immune response in the lung to P.
aeruginosa. It has been previously demonstrated that levels of antibody correlate with the clearance of P. aeruginosa following mucosal immunization [7, 35, 36] . The functional nature of this correlation is supported by studies where passive immunization using either purified IgG [37] or immune sera [34] conferred protection in this rat model of acute respiratory infection. The present study suggests that cell surface reactivity of an antigen is not always indicative of protection. Immunization with Pa13 resulted in significant bacterial clearance and was associated with significant phagocytic recruitment to the lung, however, flow cytometry analysis suggests that this antigen was not surface exposed. Whilst the flow cytometry data suggests that ACP is present on the bacterial cell surface, immunization with this protein did not significantly enhance bacterial clearance. Therefore, cell surface reactivity was not a guarantee for inducing a protective immune response. Comparison of both the ELISA and flow cytometry results indicate that ACP was less immunogenic than KatA.
Until recently, it was assumed that the most favorable antibody responses for vaccine efficacy would be generated against integral outer membrane antigenic structures. It has become clear that a number of non-integral cytosolic proteins may become absorbed to the bacterial surface. Both urease [8, 11, 12] and catalase [9, 10, 13] from Helicobacter pylori have demonstrated protective
properties including the production of antibody responses.
The process responsible for the presence of these cytosolic proteins on the bacterial surface is at present unclear. Proposed methods include a spontaneous autolysis [16] , specific and selective secretion [14] and micro vesicles [15, [17] [18] [19] . Cell surface reactivity has been demonstrated for a number of antigens in this study, all of which are considered to be periplasmically located within the bacteria.
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The development of a vaccine for cystic fibrosis patients against P. aeruginosa infection presents a major challenge. Many of the proteins in this study have functional roles, including functions that assist the bacterium to survive in vivo or to inactivate host defence mechanisms. Long-lasting mucosal immunity must be stimulated without the harmful induction of inflammatory responses in the lung. Hence, vaccine candidates will need to be assessed for their ability to strike a balance that is able to clear the infection and prevent harm to the host. Greater understanding of the mechanisms of immunity induced is required. From our studies is it concluded that these mechanisms may well be antigen and microbe specific. 
